A comparative cohort study on personalised antiplatelet therapy in PCI-treated patients with high on-clopidogrel platelet reactivity. Results of the ISAR-HPR registry. [electronic resource]
Producer: 20151015Description: 342-51 p. digitalISSN:- 2567-689X
- Aged
- Aged, 80 and over
- Blood Platelets -- drug effects
- Case-Control Studies
- Clopidogrel
- Coronary Thrombosis -- etiology
- Drug Resistance
- Drug Substitution
- Female
- Germany
- Hemorrhage -- chemically induced
- Humans
- Logistic Models
- Male
- Middle Aged
- Multivariate Analysis
- Percutaneous Coronary Intervention -- adverse effects
- Piperazines -- adverse effects
- Platelet Aggregation -- drug effects
- Platelet Aggregation Inhibitors -- adverse effects
- Platelet Function Tests
- Prasugrel Hydrochloride
- Precision Medicine
- Predictive Value of Tests
- Proportional Hazards Models
- Prospective Studies
- Purinergic P2Y Receptor Antagonists -- adverse effects
- Receptors, Purinergic P2Y12 -- blood
- Registries
- Risk Factors
- Thiophenes -- adverse effects
- Ticlopidine -- adverse effects
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.